Basic Information
Basic information for SOX9-AS1-239-54aa
Peptide Name SOX9-AS1-239-54aa
Genome Position chr17:72076005-72076166[-]
Species Human
Peptide Sequence MKAGPSACGICLFLEPIHISLWFSKVQRGHIGNFAWGLFHILEGRSLNICIGGV
Peptide Length 54
Unique No (SOX9-AS1-204-54aa,SOX9-AS1-220-54aa,SOX9-AS1-223-54aa,SOX9-AS1-225-54aa,SOX9-AS1-228-54aa,SOX9-AS1-229-54aa,SOX9-AS1-231-54aa,SOX9-AS1-232-54aa,SOX9-AS1-234-54aa,SOX9-AS1-237-54aa)
Grand Average of Hydropathicity 0.6185
Relative Molecular Mass 6850.76
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000234899;SOX9-AS1
Transcript ID/Name ENST00000671151;SOX9-AS1-239
Transcript Length 1258
Coding Ability 0.6407
DNA Sequence Corresponding to Peptide ATGAAGGCAGGGCCCAGTGCCTGTGGCATCTGCCTTTTTCTGGAACCAATCCATATTTCCTTGTGGTTTTCTAAGGTGCAGAGAGGGCACATTGGGAACTTTGCTTGGGGTCTTTTTCACATCTTAGAGGGAAGGTCCCTCAACATCTGCATTGGCGGAGTG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :